Ronnie Chan

Ronnie Chan is Chairman of Hang Lung Group Limited and its subsidiary Hang Lung Properties Limited, the latter a constituent of the Hang Seng Index. Founded in 1960 by his father, Chan Tseng-hsi, Chan assumed leadership in 1991 and spearheaded the Group’s strategic expansion into mainland China in the early 1990s. Under his direction, Hang Lung has developed, owned, and managed premier commercial complexes across key cities including Shanghai, Tianjin, Shenyang, Wuxi, Jinan, Dalian, Kunming, Wuhan, and Hangzhou.

A committed philanthropist, Chan channels his efforts primarily through the Morningside Foundation, with a strong focus on education. In 2021, the Foundation’s US$175 million donation to the University of Massachusetts Medical School led to its renaming as UMass Chan Medical School. Earlier contributions include US$350 million to Harvard University School of Public Health and US$20 million to his alma mater, University of Southern California. He also supports financially disadvantaged students at universities across China.

Chan founded the Centre for Asian Philanthropy and Society, serves as Chair Emeritus of the Asia Society, and chairs its Hong Kong Centre. He is a director of the Real Estate Developers Association of Hong Kong, an advisor to the China Development Research Foundation, and a Fellow of the American Academy of Arts and Sciences.

Previously, Chan was a non-executive director of the Securities and Futures Commission of Hong Kong, founding Chairman Emeritus of the Asia Business Council, a member of the governing board of the World Economic Forum, and a director of Standard Chartered and Motorola.

He earned a bachelor’s and master’s degree in biology from California State University, Los Angeles, an MBA from the University of Southern California in 1976, and holds honorary doctorates from Tel Aviv University, Hong Kong University of Science and Technology, and The Chinese University of Hong Kong.